NaturalNano to Present in New York City at Friedland Investment Undiscovered Equities Conference

ROCHESTER, NY, Jan 22 (MARKET WIRE) --
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N), a developer of advanced
nanomaterials and extended release nanotechnologies, today announced that
President and
Chief Technology Officer Cathy Fleischer, Ph.D. will present at the Friedland
Investment Undiscovered Equities Conference in New York City at 12:15 p.m. EST,
Wednesday, Jan. 23, 2008. The conference will be held at the DoubleTree
Metropolitan Hotel.

Fleischer commented: "This conference is an opportunity for NaturalNano to
showcase the industry-leading properties of our proprietary nanocomposite
additive,
Pleximer(TM), and the multiple advantages it holds for both manufacturers and
consumers. In addition, bringing the financial community up to speed on the
successful completion of our aggressive 2007 goals is a great way for us to
continue building on our momentum toward commercialization of our products."

NaturalNano (www.naturalnano.com) said it will also provide updates on its
licensing deal with the Naval Research Laboratory (NRL), as well as on its
overall strategy towards future product introduction.

About NaturalNano, Inc.

NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) is a materials science company
focused
on developing and commercializing advanced nanocomposites and extended
release nanotechnologies. Based in Rochester, NY, the Company is focused on
additive technologies and processes, including its proprietary Pleximer(TM)
polymer
additive, that add value to industrial polymers, plastics and composites, as
well
as consumer and industrial products. NaturalNano holds and licenses over 25
patents
and applications, as well as proprietary know-how for extraction and
separation processes, compositions, and derivatives of Halloysite and other
nanotubes.
For more information, visit http://www.naturalnano.com.

Cautionary Statement Regarding Forward-Looking Statements: This press
release
may contain forward-looking statements regarding future events and future
performanceof NaturalNano that involve risks and uncertainties that could
materially affect
actual results. This information is qualified in its entirety by cautionary
statements and risk factors disclosure contained in certain of NaturalNano's
filings with the Securities and Exchange Commission. The most recent annual
reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by
NaturalNano provide information about these factors, which may be revised or
supplemented in future reports to the SEC on those forms or on Form 8-K. We
caution investors not to place undue reliance on forward-looking statements,
and we do not undertake any obligation to update or otherwise revise any
forward-looking statements, whether as a result of new information, future
events, or other such factors that affect the subject of these statements,
except where expressly required by law.

Contact:
Patrick Kane
Karen Keller
Lambert, Edwards & Associates
616.233.0500
pkane@lambert-edwards.com

Copyright 2008, Market Wire, All rights reserved.

-0-